Brii Biosciences Statistics
Total Valuation
BRIBF has a market cap or net worth of 175.68 million. The enterprise value is -144.91 million.
| Market Cap | 175.68M |
| Enterprise Value | -144.91M |
Important Dates
The next estimated earnings date is Monday, May 19, 2025.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 719.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 521.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.32 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.08 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.81 |
Financial Position
The company has a current ratio of 31.18, with a Debt / Equity ratio of 0.01.
| Current Ratio | 31.18 |
| Quick Ratio | 29.97 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -168.55 |
Financial Efficiency
Return on equity (ROE) is -18.05% and return on invested capital (ROIC) is -8.73%.
| Return on Equity (ROE) | -18.05% |
| Return on Assets (ROA) | -8.44% |
| Return on Invested Capital (ROIC) | -8.73% |
| Return on Capital Employed (ROCE) | -15.17% |
| Revenue Per Employee | 76,877 |
| Profits Per Employee | -710,406 |
| Employee Count | 98 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.09% in the last 52 weeks. The beta is 1.62, so BRIBF's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +13.09% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 30.05 |
| Average Volume (20 Days) | 28,473 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRIBF had revenue of 7.53 million and -69.62 million in losses. Loss per share was -0.10.
| Revenue | 7.53M |
| Gross Profit | 7.53M |
| Operating Income | -54.64M |
| Pretax Income | -70.20M |
| Net Income | -69.62M |
| EBITDA | -54.33M |
| EBIT | -54.64M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 317.89 million in cash and 3.84 million in debt, giving a net cash position of 314.05 million.
| Cash & Cash Equivalents | 317.89M |
| Total Debt | 3.84M |
| Net Cash | 314.05M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 357.04M |
| Book Value Per Share | 0.50 |
| Working Capital | 320.14M |
Cash Flow
In the last 12 months, operating cash flow was -51.09 million and capital expenditures -442,246, giving a free cash flow of -51.53 million.
| Operating Cash Flow | -51.09M |
| Capital Expenditures | -442,246 |
| Free Cash Flow | -51.53M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -725.21% |
| Pretax Margin | -931.75% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRIBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.30% |
| Shareholder Yield | -0.30% |
| Earnings Yield | -39.63% |
| FCF Yield | -29.33% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BRIBF has an Altman Z-Score of 1.65. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | n/a |